SITUS MBO128 - AN OVERVIEW

Emily Bodnar’s rating relies to the anticipation of significant milestones for Agenus in the coming yr, specially the opportunity filing of a Biologics License Application (BLA) for their lead drug prospect, botensilimab (bot). Agenus has dosed about 900 clients with bot throughout several good tumors, demonstrating a motivation to intensive scie